Timing of sentinel lymph node biopsy in patients with early breast cancer undergoing neoadjuvant therapy
10.3760/cma.j.cn115396-20230131-00014
- VernacularTitle:早期乳腺癌新辅助治疗患者前哨淋巴结活检时机选择
- Author:
Jingming YE
1
;
Ling XU
;
Yinhua LIU
Author Information
1. 北京大学第一医院乳腺疾病中心，北京 100034
- Keywords:
Early diagnosis;
Breast neoplasms;
Neoadjuvant therapy;
Sentinel lymph node biopsy
- From:
International Journal of Surgery
2023;50(2):76-81
- CountryChina
- Language:Chinese
-
Abstract:
Neoadjuvant therapy has been continuously improved the outcomes of early breast cancer patients, and more patients with positive axillary lymph node achieve complete pathological responds. The timing of sentinel lymph node biopsy for patients receiving neoadjuvant therapy has also had a new strategy, especially for the patients with clinical positive axillary lymph node before treatment and become clinical negative after neoadjuvant therapy, sentinel lymph node biopsy after neoadjuvant therapy has gradually become a standard axillary surgery procedure. However, there are still many differences in clinical practice domestic in China and abroad. This article discussed the timing of sentinel lymph node biopsy in patients with early breast cancer undergoing neoadjuvant therapy, in order to draw the attention of domestic surgical colleagues to this issue and promote standardized surgery and multidisciplinary cooperation.
